Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

CIB - Condensed Balance Sheet Standalone (9M26)

10th Nov 2026 07:00

RNS Number : 4299C
Commercial Intnl Bank (Egypt) SAE
10 November 2026
 

Condensed Separate Interim Statement of Financial Position as at September 30, 2026

Click on, or paste the following link into your web browser, to view the full announcement text:http://www.rns-pdf.londonstockexchange.com/rns/4299C_1-2026-11-9.pdf

 

 

Notes

Sep. 30, 2026

 

Dec. 31, 2025

 

Assets

 

 

 

 

 

Cash and balances at the central bank

14

100,320,998

 

88,094,579

 

Due from banks

15

277,076,227

 

136,581,804

 

Loans and advances to banks, net

17

51,133,049

 

34,440,770

 

Loans and advances to customers, net

18

614,095,530

 

503,361,099

 

Derivative financial instruments

 

36,516

 

620,349

 

Financial investments

 

 

 

 

 

- Financial Assets at Fair Value through OCI

19.1

379,415,570

 

375,180,260

 

- Financial Assets at Amortized cost

19.1

328,549,745

 

234,685,457

 

Investments in subsidiaries and associates

20

9,616,565

 

1,157,430

 

Non-current assets held for sale

32

279,104

 

279,104

 

Other assets

21

57,650,643

 

53,904,113

 

Deferred tax assets

 

1,107,301

 

2,410,347

 

Property and equipment

22

6,459,471

 

5,437,519

 

Total assets

 

1,825,740,719

 

1,436,152,831

 

Liabilities and equity

 

 

 

 

 

Liabilities

 

 

 

 

 

Due to banks

23

21,826,384

 

3,796,866

 

Due to customers

24

1,452,466,360

 

1,105,355,617

 

Derivative financial instruments

 

282,234

 

137,802

 

Current income tax liabilities

 

16,081,403

 

20,570,313

 

Other liabilities

25

30,568,943

 

25,411,706

 

Issued debt instruments

26

-

 

4,761,558

 

Other loans

 

32,300,727

 

30,471,499

 

Other provisions

27

15,611,164

 

15,632,737

 

Total liabilities

 

1,569,137,215

 

1,206,138,098

 

Equity

 

 

 

 

 

Issued and paid capital

 

34,051,391

 

33,779,361

 

Reserves

 

132,132,542

 

105,426,594

 

Reserve for employee stock ownership plan (ESOP)

 

2,718,833

 

2,343,532

 

Retained earnings*

 

87,700,738

 

88,465,246

 

Total equity and net profit for the period / year

 

256,603,504

 

230,014,733

 

Total liabilities and equity

 

1,825,740,719

 

1,436,152,831

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

(Review report attached)

 

 

 

 

*

Including net profit for the period

 

 

 

 

 

Condensed Separate Interim Income Statement for The Period Ended September 30, 2026

 

 

Last 9 Months

Last 9 Months

 

Notes

Sep. 30, 2026

Sep. 30, 2025

Interest and similar income

 

174,266,929

157,761,416

Interest and similar expense

 

(81,545,566)

(79,403,286)

Net interest income

 

92,721,363

78,358,130

 

 

 

 

Fee and commission income

 

15,494,846

11,565,784

Fee and commission expense

 

(6,472,951)

(5,224,939)

Net fee and commission income

 

9,021,895

6,340,845

 

 

 

 

Dividend income

 

213,788

125,185

Net trading income

9

2,753,112

1,276,502

Profits (losses) on financial investments

19.2

360,970

598,228

Administrative expenses

 

(15,383,108)

(11,880,346)

Other operating income (expenses)

10

(4,174,858)

687,384

Release (charges) for ECL

11

1,439,075

7,976,997

Profit before income tax

 

86,952,237

83,482,925

 

 

 

 

Income tax expense

12

(23,030,304)

(21,867,730)

Deferred tax assets (liabilities)

12

(948,425)

592,311

Net profit for the period

 

62,973,508

62,207,506

 

 

 

 

Earnings per share

13

 

 

Basic

 

16.66

16.84

Diluted

 

16.45

16.64

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Islam Zekry

Hisham Ezz Al-Arab

Group CFO & Executive Board Member

CEO & Executive Board Member

 

 

Condensed Separate Interim Statement of Comprehensive Income for The Period Ended September 30, 2026

 

Last 9 Months

Last 9 Months

 

Sep. 30, 2026

Sep. 30, 2025

Net profit for the period

62,973,508

62,207,506

Transferred to RE from financial assets at fair value through OCI

-

3,586

Net change on financial assets at fair value through comprehensive income after tax

(7,623,412)

6,805,836

Effect of ECL on debt instruments measured at fair value through OCI

(1,213,889)

(399,884)

Total comprehensive income for the period

54,136,207

68,617,044

 

 

Condensed Separate Interim Cash Flows for The Period Ended September 30, 2026

 

 

Notes

Sep. 30, 2026

Sep. 30, 2025

 

Cash flow from operating activities

 

 

 

 

Profit before income tax

 

86,952,237

83,482,925

 

Adjustments to reconcile profits to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

22

1,741,775

1,244,370

 

Impairment release/charge for credit losses (loans and advances to customers and banks)

11

(831,266)

(7,980,073)

 

Net charge/release for other provisions

27

703,491

(4,080,370)

 

Impairment release/charge for credit losses (due from banks)

11

10,622

151,236

 

Impairment release/charge for credit losses (financial investments)

11

(618,431)

(148,160)

 

Exchange revaluation differences for financial assets at fair value through OCI and AC

 

(14,793,139)

4,669,694

 

Revaluation differences impairment charge for Financial Assets at Fair value through OCI

 

348,094

(225,004)

 

Revaluation differences impairment charge for Financial Assets at Amortized cost

 

14,301

(16,709)

 

Revaluation differences impairment charge for due from banks

 

12,012

(7,813)

 

Net utilized/recovered for other provisions

27

(1,205,347)

(2,039)

 

Exchange revaluation differences of other provisions

27

480,283

(52,461)

 

Profits/losses from selling property and equipment

 

(4,500)

(8,006)

 

Profits/losses from selling financial investments at fair value through OCI

19.2

(360,970)

(416,668)

 

Profits/losses from selling investments in associates

19.2

-

(181,560)

 

Share based payments

 

1,218,347

990,324

 

Operating profits before changes in operating assets and liabilities

 

73,667,509

77,419,686

 

 

 

 

 

 

Net decrease / increase in assets and liabilities

 

 

 

 

Due from banks

 

(24,164,341)

158,353,929

 

Financial assets at fair value through P&L

 

-

(2,203,869)

 

Derivative financial instruments

 

370,892

(306,569)

 

Loans and advances to banks and customers

 

(126,593,623)

(120,567,170)

 

Other assets

 

(395,375)

(2,706,703)

 

Due to banks

23

18,029,518

4,726,166

 

Due to customers

24

347,110,743

75,309,375

 

Current income tax obligations paid

 

(6,948,901)

(6,009,912)

 

Other liabilities

 

(15,413,075)

(12,872,687)

 

Net cash generated from (used in) operating activities

 

265,663,347

171,142,246

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Proceeds from sale of investments in associates

 

-

339,920

 

Payments for investment in subsidiaries

 

(8,459,135)

(542,256)

 

Payments for purchases of property, equipment and branches construction

 

(6,116,703)

(5,833,944)

 

Proceeds from selling property and equipment

10

4,500

8,006

 

Proceeds from redemption of financial assets at amortized cost

 

12,259,860

21,249,023

 

Payments for purchases of financial assets at amortized cost

 

(105,671,194)

(83,115,289)

 

Payments for purchases of financial assets at fair value through OCI

 

(154,612,829)

(192,334,673)

 

Proceeds from selling financial assets at fair value through OCI

 

157,194,816

98,063,752

 

Net cash generated from (used in) investing activities

 

(105,400,685)

(162,165,461)

 

Condensed Separate Interim Cash Flows for The Period Ended September 30, 2026 (Cont.)

 

 

 

Sep. 30, 2026

Sep. 30, 2025

 

Cash flow from financing activities

 

 

 

 

Other loans

 

1,829,228

6,286,889

 

Dividends

 

(29,037,813)

(14,714,434)

 

Issued debt instruments

 

(4,761,558)

(288,320)

 

Capital increase

 

272,030

276,930

 

Net cash generated from (used in) financing activities

 

(31,698,113)

(8,438,935)

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalent during the period

 

128,564,549

537,850

 

Beginning balance of cash and cash equivalent

 

141,266,643

227,028,744

 

Cash and cash equivalent at the end of the period

 

269,831,192

227,566,594

 

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

Cash and balances at the central bank

14

100,320,998

20,916,631

 

Due from banks

 

277,231,543

228,295,965

 

Treasury bills and other governmental notes

16

185,717,863

140,546,840

 

Obligatory reserve balance with CBE

 

(73,614,596)

(2,725,245)

 

Due from banks with maturity more than three months

 

(34,106,753)

(19,202,757)

 

Treasury bills and other governmental notes with maturity more than three months

 

(185,717,863)

(140,264,840)

 

Total cash and cash equivalent

 

269,831,192

227,566,594

 

 

Condensed Separate Interim Statement of Changes in Shareholders' Equity

Sep. 30, 2025

Issued and paid capital

Legal reserve

General reserve

General risk reserve

Special reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

 

 

Beginning Balance

30,431,580

6,208,674

62,422,792

1,549,445

-

22,818

(7,095,741)

17,924

56,260,451

1,868,235

151,686,178

Capital increase

276,930

-

-

-

-

-

-

-

-

-

276,930

Transferred to reserves

-

2,771,284

19,758,610

-

-

2,246

-

-

(21,744,828)

(787,312)

-

Dividend paid

-

-

-

-

-

-

-

-

(14,714,434)

-

(14,714,434)

Net profit for the period

-

-

-

-

-

-

-

-

62,207,506

-

62,207,506

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

3,586

-

(3,586)

-

-

Transferred from net profit to special reserve

-

-

-

-

13,145,012

-

-

-

(13,145,012)

-

-

Net change on financial assets at fair value through OCI after tax

-

-

-

-

-

-

6,805,836

-

-

-

6,805,836

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

(2,628)

2,628

-

-

Effect of ECL on debt instruments measured at fair value through OCI

-

-

-

-

-

-

(399,884)

-

-

-

(399,884)

Cost of employees' stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

990,324

990,324

 Ending Balance

30,708,510

8,979,958

82,181,402

1,549,445

13,145,012

25,064

(686,203)

15,296

68,862,725

2,071,247

206,852,456

 

 

 

 

 

 

 

 

 

 

 

 

 

Sep. 30, 2026

Issued and paid capital

Legal reserve

General reserve

General risk reserve

Special reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

 

 

Beginning Balance

33,779,361

8,979,958

79,110,551

1,549,445

13,145,012

25,064

2,601,268

15,296

88,465,246

2,343,532

230,014,733

Capital increase

272,030

-

-

-

-

-

-

-

-

-

272,030

Transferred to reserves

-

4,089,832

31,449,216

-

-

13,005

-

-

(34,709,007)

(843,046)

-

Dividends paid

-

-

-

-

-

-

-

-

(29,037,813)

-

(29,037,813)

Net profit for the period

-

-

-

-

-

-

-

-

62,973,508

-

62,973,508

Net change on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(7,623,412)

-

-

-

(7,623,412)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

(8,804)

8,804

-

-

Effect of ECL on debt instruments measured at fair value through OCI

-

-

-

-

-

-

(1,213,889)

-

-

-

(1,213,889)

Cost of employees' stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

1,218,347

1,218,347

 Ending Balance

34,051,391

13,069,790

110,559,767

1,549,445

13,145,012

38,069

(6,236,033)

6,492

87,700,738

2,718,833

256,603,504

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTBIBDBRDGDGLC

Related Shares:

Com.int.bk.regs
FTSE 100 Latest
Value10,793.59
Change42.00